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Objectives: Increasing evidences show that OX40-OX40L interaction plays an
important role in atherosclerosis. However, the mechanism of OX40 signaling
pathway has not been clariﬁed. The objective of this study was to investigate the effect
of OX40-OX40L interaction on intracellular reactive oxygen species (ROS) level and
the secretion of Cyclophilin A (CyPA) in C57BL/6J mice’ atherogenesis.
Methods: Atherosclerotic plaque model was produced by rapid perivascular carotid
collar placement plus western-type diet in C57BL/6J mice. In vivo, the expression of
CyPA in mice plaque and lymphocytes was detected by immunohistochemical and
Western blot, respectively. In vitro, the expression of CyPA protein in cultured
lymphocytes of C57BL/6J mice was measured by Western blot. The level of ROS was
detected by ﬂow cytometry.
Results: We found that the expression of CyPA was signiﬁcantly increased both in
atherosclerotic lesion and in lymphocytes from C57BL/6J mice. In vitro and in vivo,
the level of ROS in OX40+lymphocytes was increased. In vitro, after stimulating
OX40-OX40L interaction, the levels of ROS and CyPA in lymphocytes were obvi-
ously increased, while anti-OX40L mAb signiﬁcantly down-regulated the anti-OX40
mAb-induced ROS generation and inhibited lymphocytes to secrete CyPA in
lymphocytes.
Conclusions: This study suggested that OX40-OX40L interactions can up-regulate
the intracellular level of ROS in C57BL/6J mice and increase the secretion of CyPA
from lymphocytes, which might play a critical role in atherosclerotic plaque
formation.
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Lycopene ameliorates pressure overload-induced cardiac hypertrophy and
ﬁbrosis via increase in PPAR g expression and inhibition of NF-kB nuclear
binding
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Objectives: Lycopene plays a protective role in hypertension, atherosclerosis, and
hyperlipidemia through scavenge free radicals and it’s anti-inﬂammatory ability. The
present study was designed to investigate the role of lycopene in cardiac hypertrophy
and ﬁbrosis in pressure overload model
Methods: C57BL/6 mice, 8 weeks of age, were subjected to transverse aortic
constriction (TAC) surgery and randomly divided into TAC group, TAC+Lycopene
group and TAC+Lycopene+GW9662 (PPAR g inhibitor) group. In TAC+Lycopene
group, the mice subjected to were fed with lycopene for four weeks. In TAC+Ly-
copene+GW9662 group, the mice were fed with lycopene and GW9662 at the same
time for four weeks. While, in TAC group, the mice was just fed with corn oil. The
characteristics of heart functions were evaluated by the methods of hemodynamics and
echocardiography.Masson staining was employed to observe the pathological changes
of myocardial tissues.Metalloproteinase (MMP) -2, MMP-9 and MMP-13 were
detected through Western Blot. The expression of PPAR g and the NF-kB activity
were also detected.
Results: Dietary lycopene signiﬁcantly attenuates pressure overload-induced increase
in heart weight index, enlargement of ventricular volume, decrease in cardiac function,
and worse in cardiac ﬁbrosis. Additionally, lycopene attenuated pressure overload-
induced over-expression of metalloproteinase (MMP) -2, MMP-9 and MMP-13.
Moreover, the expression PPAR g was signiﬁcantly increased while the NF-kB ac-
tivity was signiﬁcantly decreased in the TAC+lycopene group. However, these pro-
tective effects were blunted by GW9662 (PPAR g inhibitor), the expression of PPAR
g and the NF-kB activity was restored in the TAC+Lycopene+GW9662 group.
Conclusions: Our results suggest that dietary lycopene protects against cardiac hy-
pertrophy and ﬁbrosis in pressure overload mice via increase in PPAR g expression
and inhibition of NF-kB nuclear binding.
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Objectives: Pulmonary hypertension syndrome, also known as ascites, is a com-
mon disease occurred in broiler chickens under conditions such as high altitude or
low ambient temperatures. However, its mechanism is not clear. Studies show that
dysregulated renin-Angiotensin system (RAS) contributes to increased pulmonary
vascular remodeling and local RAS-upregulation was associated with increased
pulmonary artery smooth muscle cell proliferation via enhanced angiotensin type 1
receptor (AT1-R) signaling in patients with idiopathic pulmonary arterial hyper-
tension. Angiotensin (Ang) II, the main the major biologically active component
of RAS, acts through AT1 receptor and AT2 receptor (AT2- R). AT1-R is
responsible for mediating many of the well-known stimulatory pathological actions
of Ang II including secretion of aldosterone, vasoconstriction, and renal sodium
reabsorption. Telmisartan is the inhibitor of AT1-R. This study aims to exploreC12 JACC Vol 64/16/Suppl C j Octobthe protective effect of Telmisartan, Angiotensin type 1 receptor blocker, on
pulmonary arterial remodeling induced by low ambient temperature in broiler
chickens.
Methods: Ninety chickens were randomly divided into 3 groups (n¼30), including
control group, low temperature group and telmisartan group. Chickens in low tem-
perature group and telmisartan group were exposed to low ambient temperature from
14 days of age until 45 days of age; chickens in telmisartan group were gavaged with
telmisartan 5 mg/kg once daily for thirty days. The pulmonary arterial systolic pres-
sure was measured with Right Catheterization Method. Wet lung weight index and
right ventricular hypertrophy index were evaluated. Small pulmonary artery wall
thickness and elastic ﬁbers was determined respectively by H-E staining and Weight
staining. Proliferating cell nuclear antigen (PCNA) -positive cells were determined by
Immunohistochemical staining.
Results: It showed that pulmonary arterial systolic pressure, wet lung weight index
and right ventricular hypertrophy index, small pulmonary artery wall thickness, elastic
ﬁbers and PCNA expression increased signiﬁcantly in Low temperature group
compared with control group and telmisartan group.
Conclusions: Telmisartan can protect broiler chickens from pulmonary arterial
remodeling induced by low ambient temperature.
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Objectives: Previous studies found that overexpression of mitofusin 2 (Mfn2) inhibits
atherosclerotic plaque formation. Mfn2 is also decreased in atherosclerotic arteries of
apoE-/- mice but studies have not yet extended to the effects of Mfn2 on cholesterol
transport in foam cell formation. The aim of this study was to determine whether Mfn2
was involved in cholesterol transport in foam cell formation.
Methods: Arteries of both mice and human were obtained to anlysis the Mfn2 mRNA
and protein expression in atherosclerotic plaque. Using THP-1 as a macrophage
model, we used oil red O staining and cellular cholesterol content analysis to deter-
mine the effect of overexpression of Mfn2 on macrophage-derived foam cell forma-
tion. Then, western blot and quantitative real-time polymerase chain reaction were
used to detect the protein and mRNA expression in cells.
Results: This study showed that Mfn2 expression was signiﬁcantly reduced in arterial
atherosclerotic lesion in both mice and human compared to healthy counterparts.
Then, cellular cholesterol content analysis and oil red O revealed that Mfn2 over-
expression decreased the accumulation of cholesterol esters induced by exposure to
oxidized low density lipoprotein (ox-LDL) in macrophages. Mfn2 promoted choles-
terol transport by regulating expression of ABCA1, ABCG1 and SR-BI protein and
mRNA in a titer-dependent manner in THP-1-derived foam cells. However, silencing
Mfn2 gene with siRNA nearly reversed the upregulation of ABCA1, ABCG1 and SR-
BI expression. In addition, peroxisome proliferator-activated receptor-g (PPARg) and
liver X receptor-a (LXRa), which induced the activation of cellular cholesterol efﬂux
pathway, were also activated by adenovirus-mediated Mfn2 (adv-Mfn2) transfection.
Furthermore, the down- regulation of cholesterol transporters and PPARg by siRNA-
Mfn2 was rescued by the PPARg agonist rosiglitazone and mitogen-activated protein
kinase (MAPKs) inhibitors SB203580 and PD98059, indicating that MAPKs was
involved in Mfn2-induced PPAR activation and cholesterol efﬂux.
Conclusions: Our studies provide new insights into potential mechanisms of Mfn2-
mediated alterations in cellular cholesterol transport which may impact the develop-
ment of atherosclerosis.
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Objectives: Stem cell transplantation has had modest success as a treatment for
myocardial infarction (MI). One of the limitations is the poor stem cell survival and
function in the diseased microenvironment. We studied whether and how prolyl hy-
droxylase domain protein 2 (PHD2), a cellular oxygen sensor, enhances stem cell
cardioprotective effects after transplantation into infarcted hearts.
Methods: We ﬁrst used adipose-derived stem cells (ADSCs), and then conﬁrmed our
ﬁndings in bone marrow mesenchymal stem cells (BM-MSCs). ADSCs were trans-
duced with lentiviral short hairpin RNA to silence PHD2 (shPHD2) and intra-
myocardially injected into infarcted heart in mice.
Results: ADSCs reduced cardiomyocyte apoptosis, ﬁbrosis, and infarct size
(MI+ADSCs: 39.43.3%;MI+PBS: 48.44.5%) and improved cardiac functioner 16–19, 2014 j GW-ICC Abstracts/Basic and Translational Medicine
(MI+ADSCs: 43.85.6%; MI+PBS: 37.23.0%). ShPHD2-ADSCs exerted signiﬁ-
cantly more protection (infarct size: 22.63.0%; LVEF: 67.36.8%; P<0.05 vs.
MI+ADSCs). PHD2 silencing induced greater ADSC survival (survival rate at 7 days
post-transplantation: shPHD2-ADSCs: 14.74.2% vs. ADSCs: 3.40.8%, P<0.05),
which was abolished by HIF-1alpha silencing. None of the ADSCs gave rise to
cardiomyocytes, and ADSC-induced cardioprotection was mainly induced by para-
crine function. Conditioned medium from shPHD2-ADSCs decreased cardiomyocyte
apoptosis. Insulin-like growth factor-1 (IGF-1) levels were 3.8 times higher in the
conditioned medium of shPHD2-ADSCs than ADSCs, and depletion of IGF-1
attenuated the cardioprotective effects of shPHD2-ADSC-conditioned medium.
NF-kappaB activation was induced by shPHD2 to stimulate IGF-1 secretion via
binding to the IGF-1 gene promoter. A combination of HIF-1alpha silencing and IGF-
1 neutralization blocked the beneﬁcial effects of shPHD2-ADSCs for MI. Similar
ﬁndings were observed with BM-MSCs.
Conclusions: PHD2 silencing promotes stem cell survival in infarcted hearts and
enhances their paracrine function to protect cardiomyocytes. Its prosurvival effect on
stem cells is HIF-1alpha dependent, while it enhances stem cell paracrine function
through NF-kappaB-mediated IGF-1 upregulation. PHD2 silencing in stem cells may
be a novel strategy for enhancing the effectiveness of stem cell therapy after MI.
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Objectives: To investigate the role of Interluekin1 receptor-associated kinase-4
(IRAK4), which plays an essential role in the innate immune system, in cardiac
remodeling induced by pressure overload and elucidate the underlying mechanisms.
Methods: In vivo studies were performed using IRAK4 heterozygous knockout
(IRAK4+/-) mice and wild type (IRAK4+/+) mice. Models of cardiac remodeling were
induced by aortic banding (AB). Cardiac remodeling was evaluated by Echocardi-
ography, catheter-based measurements of hemodynamic parameters and histological
analysis. In vitro studies were performed using H9c2 cardiomyoblasts with over-
expression of IRAK4 or not. Models of cardiomyoblast hypertrophy were induced by
Angiotension II (AngII) treatment. Cardiomyoblast hypertrophy was evaluated by
immunoﬂuorescent staining of a-actin. mRNA and protein expression were detected
by real-time PCR and Western Blot analysis.
Results: IRAK4 was upregulated in pressure overload induced mice heart. IRAK4+/-
mice exhibited exacerbated cardiac hypertrophy, dysfunction and ﬁbrosis after 4
weeks of aortic banding (AB) compared with that in wild-type mice. Furthermore,
enhanced activation of the MEK-ERK1/2, p38 and NFkB pathways was found in
IRAK4+/- mice compared to WT mice.
While IRAK4 overexpression signiﬁcantly attenuated cardiomyoblasts hypertrophy
induced by AngII accompaning with decreased expression of hypertrophic markers,
including atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP) and
decreased activation of the MEK-ERK1/2, p38 and NFkB pathways.
Conclusions: IRAK4 may play a crucial role in the development of cardiac remod-
eling via negative regulation of mutiple signaling pathways.
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miRNA-31 expression in human coronary artery endothelial cells exposed to
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Objectives: Diabetes is high risk factor for cardiovascular disease including athero-
sclerosis and coronary heart disease. Vascular endothelial dysfunction is the initiating
factor and early manifestation of diabetic vascular disease. Our preliminary study has
shown that sphingosine-1-phosphate (S1P) was signiﬁcantly increased in serum of
diabetic rats. sphingosine-1-phosphate receptor type 2 (S1PR2) was the overwhelming
S1P receptor expressing in human coronary artery endothelial cells (HCAECs)
exposed to high glucose condition. The present study explored the role of S1P/S1PR2
in diabetic vascular endothelial dysfunction and underlying mechanism, which may
provide S1P/S1PR2 pathway as therapeutic target to prevent and treat vascular
endothelial dysfunction in diabetes mellitus.
Methods: NO level, endothelial nitric oxide synthase (eNOS), intercellular adhesion
molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) protein
expression were measured in HCAECs by commercial kit and western blot, respec-
tively. MiRNA-31 level was detected by real-time PCR. After treatment by different
methods including S1PR2 speciﬁc antagonist, small molecular RNA interference,
overexpression of S1PR2, tranfection of miRNA mimic and inhibitor respectively, the
above indexes of endothelia cells function were investigated in HCAECs cultured
under 25mM high glucose condition. The target gene of miRNA-31 was predicted
using microRNA on-line analysis software and validated by dual-luciferase reporter
gene system and western blot.
Results: NO level and eNOS protein level were decreased, ICAM-1 and VCAM-1
protein level were increased signiﬁcantly in HCAECs by S1P treatment or S1PR2
overexpression. The enhanced NO level and eNOS protein as well as the decreasedJACC Vol 64/16/Suppl C j October 16–19, 2014 j GW-ICC Abstracts/BICAM-1 and VCAM-1 protein expression were observed after treatment with
sphingosine kinase-1 inhibitor DMS, S1PR2 speciﬁc antagonist JTE-013 and speciﬁc
S1PR2-siRNA respectively in HCAECs induced by S1P under high glucose condi-
tion. MiRNA-31 expression in indicated cells induced by S1P was also inhibited by
JTE-013 and S1PR2-siRNA. Moreover, the HCAECs co-transfected S1PR2-siRNA
and miRNA-31 mimic were shown the decreased in NO level and eNOS protein level
while the increased in adhesion molecule protein expression including ICAM-1 and
VCAM-1. The reversal effects were found in HCAECs overexpressed S1PR2 and
transfected miRNA-31 inhibitor together. Additionally, microRNA on-line analysis
software was used to predict the target of miRNA-31 and found that there was possible
binding sequence of miRNA-31 in human eNOS mRNA 3’-UTR. Furthermore, the
result of dual luciferase reporter gene experiment shown that the luciferase activities
were inhibited by overexpressed miRNA-31 at the presence of the wild type human
eNOS mRNA 3’-UTR, which can be abrogated by mutations in seed complementary
site. Protein expression of eNOS in miRNA-31 transduced cells was examined to be
suppressed after miRNA-31 transfection. Together, our results demonstrated that
eNOS was direct target of miRNA-31.
Conclusions: S1P/S1PR2 mediated vascular endothelial cells dysfunction by upre-
gulating miRNA-31 expression in HCAECs exposed to high glucose.
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Objectives: To study the association of platelet membrane glycoprotein poly-
morphism (GP I aC807T, GP I baKOZAK-5T/C, GP VI T13254/C, HPA-1 and HPA-
2) and coronary heart disease (CHD).
Methods: A case-control study design was adopted. The study group consisted of
150 patients (mean age¼63.9110.45 year) with coronary artery disease identiﬁed
by coronary angiography and 153 individuals (mean age¼64.6510.80 year)
without coronary artery disease. A newly-developed technology named improved
Multiplex Ligation Detection Reaction, iMLDR, was used to detect target genes and
SNPs. The risk factors for coronary artery disease were analyzed by logistic
regression.
Results: (1) For GP I aC807T, the comparisons of genotype and allele distributions
between cases and controls were signiﬁcant statistically (X2¼6.640, P¼0.036 and
X2¼5.725,P¼0.017, respectively). But for GP I baKOZAK-5T/C, GP VI T13254/C,
HPA-1 and HPA-2, the distributions of genotypes and alleles were not different
signiﬁcantly between cases and controls respectively. (2) Even adjusted by gender,
blood glucose, ﬁbrinogen and triglyceride, still the results from logistic analysis
showed that more than 4 times risks for coronary artery disease were increased by TT
genotype than CC genotype of GP I aC807T. (3) An association between mutant allele
numbers of platelete membrane glycoprotein included in this study and coronary
lesion was found by logistic regression analysis (OR¼1.36,P¼0.008,95%CI¼1.082-
1.707).
Conclusions: Even though traditional risk factors were still important causes of
coronary artery disease, the genetic risk factors should not be neglected. The poly-
morphism of GP I aC807T correlates signiﬁcantly with coronary artery disease, and
TT genotype is independent risk factor for coronary artery disease.
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Objectives: AngiotensinII (AngII) as an important pro-inﬂammatory factor pro-
motes the pathogenesis of hypertension remarkably, regardless in arteries or hearts.
The activation of Toll-like receptor 4 (TLR4) is one of key pathogenic factors of
the development of hypertension via expressing different kinds of cytokines.
Peroxisome proliferator-activated receptorg (PPARg) has been proved to play a
crucial role in the negative regulation of inﬂammation in many organs and the
growing evidences exhibit that the beneﬁts of PPARg agonists in hypertension
may been via its anti-inﬂammatory and antiﬁbrotic effects. The present study
evaluated the regulation of AngII-induced inﬂammatory responses by pioglitazone
both in vivo and vitro.
Methods: Hypertension spontaneous rats (SHRs) and Wistar Kyto rats (WKYs) were
treated with pioglitazone or saline for 8 weeks. Left ventricular tissues were harvest
for further analysis. Real-time RT-PCR, immunohistochemistry, western blot and
ELISA assay were performed in cultured cardiac ﬁbroblast cells or heart tissue. MTT
assay and ﬂow cytometry were used to measure cell proliferation.
Results: The rise of systolic blood pressure in SHRs was attenuated by pioglitazone.
In SHRs, the generation of monocyte chemotactic protein-1 (MCP-1), tumor necrosis
factor-a (TNF-a), TLR4, myeloid differentiation primary response gene 88 (Myd88)
and Nuclear factor kB (NF-kB) were remarkably increased; however, cotreatment
with pioglitazone diminished these changes and increased the nuclear-PPARg
expression. Treatment of CFs with TLR4 small-interfering RNA (siRNA) show thatasic and Translational Medicine C13
